F2G

Last updated: August 28, 2025

CEO - Francesco Maria Lavino
CEO - Francesco Maria Lavino
UK | Funding: $383.3M (+)

Website: https://www.f2g.com/

F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.